Literature DB >> 10577753

Characterization of epithelial cell activity in patients with oral cancer.

P J Thomson1, C S Potten, D R Appleton.   

Abstract

Accurate, predictive assessment of the clinical behaviour and progression of individual oral cancers and premalignant lesions requires reproducible and quantitative analyses of diseased tissue. In this paper we describe the use of in vitro double labelling (sequential tritiated thymidine and bromodeoxyuridine staining of proliferating epithelial cells) to calculate S phase labelling indices (LIs), estimation of S phase duration (tS), and measurement of variables of flux to and from S for excised specimens of oral squamous cell carcinoma, premalignant lesions, and clinically normal mucosa from patients with oral cancer. There was a significant increase in mean LIs in buccal mucosa leukoplakias (14.5%) compared with normal mucosa (10.3%); P = 0.03. LIs were also increased in patients with cancers of the floor of mouth and ventral tongue but neither these changes nor alterations in flux parameters or S Phase durations were significant. Twenty-one kinetic profiles of dysplastic and malignant tissue were compared with conventional histopathological results, however, and these showed a 2.2% increase in LIs with each increase in grade of dysplasia (P = 0.004) and a 12% increase in LIs with each reduction in tumour differentiation (P = 0.02).

Entities:  

Mesh:

Year:  1999        PMID: 10577753     DOI: 10.1054/bjom.1999.0147

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  2 in total

1.  Image analysis assisted study of mitotic figures in oral epithelial dysplasia and squamous cell carcinoma using differential stains.

Authors:  Ankita Tandon; Narendra Nath Singh; V R Brave; Gadiputi Sreedhar
Journal:  J Oral Biol Craniofac Res       Date:  2016-09-28

2.  Epithelial cell proliferative activity and oral cancer progression.

Authors:  P J Thomson; J V Soames; C Booth; J A O'Shea
Journal:  Cell Prolif       Date:  2002-08       Impact factor: 6.831

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.